Targeting Her-2/neu in Breast Cancer: As Easy as This!

Publisher： Karger

E-ISSN： 1423-0232|74|3-4|150-157

ISSN： 0030-2414

Source： Oncology, Vol.74, Iss.3-4, 2008-08, pp. : 150-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J.   Ricci Jr. Andrew  

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

HER2/neu vaccines in breast cancer

By Khoo Steven   Ponniah Sathibalan   Peoples George E  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 217-223

Future Medicine

Access to resources Recommend Favorite

Her-2/neu Overexpression Due to Polysomy 17 in Breast Cancer: Molecular Testing to Guide Therapeutic Options

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 356-360

Karger

Access to resources Recommend Favorite

Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-01 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite